Meitav Dash Investments LTD Gsk PLC Transaction History

Meitav Dash Investments LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$34.27 - $40.01 $575,736 - $672,168	-16,800 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$34.07 - $39.94 $265,746 - $311,532	7,800 Added 86.67%	16,800 $622,000
Q3 2020 Nov 05, 2020	BUY	$38.11 - $42.99 $144,818 - $163,362	3,800 Added 73.08%	9,000 $337,000
Q2 2020 Aug 10, 2020	BUY	$37.87 - $43.58 $196,924 - $226,616	5,200 New	5,200 $212,000
Q1 2020 May 11, 2020	SELL	$32.47 - $48.83 $162,350 - $244,150	-5,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$39.4 - $42.7 $197,000 - $213,500	5,000 New	5,000 $200,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Meitav Dash Investments LTD with notifications on news.